what is a retatrutide Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide is being talked about

A study published in JHEP Reports in 2025 followed 29 participants with liver disease over 12 weeks

A Type II variation application has been submitted to the European Medicines Agency (EMA) seeking the approval of teclistamab (Tecvayli) monotherapy for the treatment of adult patients with relapsed/refractory multiple myeloma who have received at least 1 prior line of therapy.1 The application is supported by data from the phase 3 MajesTEC-9 trial (NCT05572515), which showed that teclistamab reduced the risk of disease progression or death by 71% compared with standard-of-care (SOC) therapy (HR, 0.29

Some GLP-1 agents have expanded into adolescent populations for diabetes management with appropriate clinical oversight

Its like hitting the reset button for your bodyyour energy picks up, and your mind sharpens

Double down on nutrient-dense food choices and meal timing strategies

Whether you have mild misalignment or more complex orthodontic needs, KLOwen braces can help